Literature DB >> 29356988

The biological changes of umbilical cord mesenchymal stem cells in inflammatory environment induced by different cytokines.

Chao Yang1, Yu Chen1, Fan Li1, Min You1, Liwu Zhong1, Wenxian Li1, Bo Zhang1, Qiang Chen2.   

Abstract

Mesenchymal stem cells (MSCs) are used as therapeutic tool for the treatment of immune diseases. The inflammatory environment also influences the characteristics of MSCs after transplantation. The aim of the study was to investigate the effects of pro-inflammatory cytokines on the characteristics of umbilical cord mesenchymal stem cells (UCMSCs). UCMSCs were exposed to pro-inflammatory cytokines in vitro for 3 and 7 days, and the biological properties were analyzed. The results showed that the proliferation ability was suppressed by interferon-γ (IFN-γ), tumor necrosis factor-α (TNF-α), and interleukin-1β (IL-1β). The adipogenic capacity was inhibited in all conditioned medium, while the chondrogenic and osteogenic capacity was enhanced by TNF-α and IL-1β in vitro. Prostaglandin E2 (PGE2) was increased by IL-1β on the third day, and angiopoietin-1 (Ang-1) was inhibited appreciably by TNF-α on the seventh day. Interleukin-6 (IL-6) was increased by TNF-α and IL-1β, and hepatocyte growth factor (HGF) was inhibited by all inflammatory cytokines. IFN-γ secretion level from human peripheral mononuclear cells (hPBMCs) was lowered by UCMSCs which had been stimulated by TNF-α or IL-1β for 3 days. Moreover, IFN-γ and TNF-α secretion level was only inhibited by UCMSCs which had been by stimulated IFN-γ for 3 days but not 7 days. Our data demonstrated that different inflammatory cytokines and the duration of treatment had different effects on the properties of UCMSCs, which might be instructive for clinical pretreatment in cellular therapeutics.

Entities:  

Keywords:  Differentiation; Immunomodulatory capacity; Paracrine; Pro-inflammatory cytokines; Proliferation; Umbilical cord mesenchymal stem cells

Mesh:

Substances:

Year:  2018        PMID: 29356988     DOI: 10.1007/s11010-018-3284-1

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  38 in total

1.  Paracrine effect of inflammatory cytokine-activated bone marrow mesenchymal stem cells and its role in osteoblast function.

Authors:  Cheng Li; Guoqiang Li; Meng Liu; Tiantian Zhou; Haibin Zhou
Journal:  J Biosci Bioeng       Date:  2015-08-25       Impact factor: 2.894

Review 2.  Ectodermal Differentiation of Wharton's Jelly Mesenchymal Stem Cells for Tissue Engineering and Regenerative Medicine Applications.

Authors:  Sushma Jadalannagari; Omar S Aljitawi
Journal:  Tissue Eng Part B Rev       Date:  2015-01-30       Impact factor: 6.389

Review 3.  Effects of inflammation on stem cells: together they strive?

Authors:  Caghan Kizil; Nikos Kyritsis; Michael Brand
Journal:  EMBO Rep       Date:  2015-03-04       Impact factor: 8.807

Review 4.  Discarded Wharton jelly of the human umbilical cord: a viable source for mesenchymal stromal cells.

Authors:  Nate Watson; Ryan Divers; Roshan Kedar; Ankur Mehindru; Anuj Mehindru; Mia C Borlongan; Cesar V Borlongan
Journal:  Cytotherapy       Date:  2014-10-18       Impact factor: 5.414

5.  Human mesenchymal stem cells modulate allogeneic immune cell responses.

Authors:  Sudeepta Aggarwal; Mark F Pittenger
Journal:  Blood       Date:  2004-10-19       Impact factor: 22.113

6.  Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease.

Authors:  Mark L Weiss; Satish Medicetty; Amber R Bledsoe; Raja Shekar Rachakatla; Michael Choi; Shosh Merchav; Yongquan Luo; Mahendra S Rao; Gopalrao Velagaleti; Deryl Troyer
Journal:  Stem Cells       Date:  2005-10-13       Impact factor: 6.277

7.  The role of IL-6 in bone marrow (BM)-derived mesenchymal stem cells (MSCs) proliferation and chondrogenesis.

Authors:  Haixiang Wei; Gan Shen; Xiaolong Deng; Dong Lou; Binbin Sun; Hao Wu; Long Long; Tao Ding; Jian Zhao
Journal:  Cell Tissue Bank       Date:  2013-01-17       Impact factor: 1.522

8.  Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation.

Authors:  Roland Meisel; Andree Zibert; Maurice Laryea; Ulrich Göbel; Walter Däubener; Dagmar Dilloo
Journal:  Blood       Date:  2004-03-04       Impact factor: 22.113

9.  Human umbilical cord provides a significant source of unexpanded mesenchymal stromal cells.

Authors:  Akie Kikuchi-Taura; Akihiko Taguchi; Takayoshi Kanda; Takayuki Inoue; Yukiko Kasahara; Haruka Hirose; Iori Sato; Tomohiro Matsuyama; Takayuki Nakagomi; Kenichi Yamahara; David Stern; Hiroyasu Ogawa; Toshihiro Soma
Journal:  Cytotherapy       Date:  2012-02-20       Impact factor: 5.414

10.  Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism.

Authors:  Farida Djouad; Louis-Marie Charbonnier; Carine Bouffi; Pascale Louis-Plence; Claire Bony; Florence Apparailly; Céline Cantos; Christian Jorgensen; Danièle Noël
Journal:  Stem Cells       Date:  2007-05-17       Impact factor: 6.277

View more
  9 in total

Review 1.  Mesenchymal Stem/Progenitor Cells: The Prospect of Human Clinical Translation.

Authors:  Dina Rady; Marwa M S Abbass; Aiah A El-Rashidy; Sara El Moshy; Israa Ahmed Radwan; Christof E Dörfer; Karim M Fawzy El-Sayed
Journal:  Stem Cells Int       Date:  2020-08-11       Impact factor: 5.443

Review 2.  Stem cell-based therapy for human diseases.

Authors:  Duc M Hoang; Phuong T Pham; Trung Q Bach; Anh T L Ngo; Quyen T Nguyen; Trang T K Phan; Giang H Nguyen; Phuong T T Le; Van T Hoang; Nicholas R Forsyth; Michael Heke; Liem Thanh Nguyen
Journal:  Signal Transduct Target Ther       Date:  2022-08-06

3.  Comparative evaluation of proliferative potential and replicative senescence associated changes in mesenchymal stem cells derived from dental pulp and umbilical cord.

Authors:  Monalisa Das; Ankita Das; Ananya Barui; Ranjan Rashmi Paul
Journal:  Cell Tissue Bank       Date:  2021-04-26       Impact factor: 1.522

4.  Genetically Modified Mouse Mesenchymal Stem Cells Expressing Non-Structural Proteins of Hepatitis C Virus Induce Effective Immune Response.

Authors:  Olga V Masalova; Ekaterina I Lesnova; Regina R Klimova; Ekaterina D Momotyuk; Vyacheslav V Kozlov; Alla M Ivanova; Olga V Payushina; Nina N Butorina; Natalia F Zakirova; Alexander N Narovlyansky; Alexander V Pronin; Alexander V Ivanov; Alla A Kushch
Journal:  Vaccines (Basel)       Date:  2020-02-02

Review 5.  The therapeutic applications of mesenchymal stromal cells from human perinatal tissues in autoimmune diseases.

Authors:  Chao Yang; Mingjun Wu; Min You; Yu Chen; Maowen Luo; Qiang Chen
Journal:  Stem Cell Res Ther       Date:  2021-02-04       Impact factor: 6.832

6.  Interleukin-33 Amplifies Human Mast Cell Activities Induced by Complement Anaphylatoxins.

Authors:  Peter W West; Rajia Bahri; Karen M Garcia-Rodriguez; Georgia Sweetland; Georgia Wileman; Rajesh Shah; Angeles Montero; Laura Rapley; Silvia Bulfone-Paus
Journal:  Front Immunol       Date:  2021-02-01       Impact factor: 7.561

7.  Adipose-Derived Stem Cells From Patients With Ulcerative Colitis Exhibit Impaired Immunosuppressive Function.

Authors:  Xiaoyun Wu; Yongxu Mu; Jingyi Yao; Fuhong Lin; Daocheng Wu; Zhijie Ma
Journal:  Front Cell Dev Biol       Date:  2022-02-18

8.  Honey-incorporated nanofibre reduces replicative senescence of umbilical cord-derived mesenchymal stem cells.

Authors:  Ankita Das; Pallab Datta; Amit Roy Chowdhury; Ananya Barui
Journal:  IET Nanobiotechnol       Date:  2020-12       Impact factor: 1.847

9.  The Paracrine Function of Mesenchymal Stem Cells in Response to Pulsed Focused Ultrasound.

Authors:  Mehdi Razavi; Melika Rezaee; Arsenii Telichko; Hakan Inan; Jeremy Dahl; Utkan Demirci; Avnesh S Thakor
Journal:  Cell Transplant       Date:  2020 Jan-Dec       Impact factor: 4.064

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.